Jean Jacques Bienaime - Sep 9, 2021 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: Chief Executive Officer, Director
Signature: /s/ Eric Fleekop, Attorney-in-Fact
Stock symbol: BMRN
Transactions as of: Sep 9, 2021
Transactions value $: -$126,893
Form type: 4
Date filed: 12/2/2021, 08:42 PM
Previous filing: Jun 23, 2021
Next filing: Oct 22, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Small acquisition under Rule 16a-6	$3.94K	+50	+0.02%	$78.77	306K	Sep 9, 2021	Direct
transaction	BMRN	Common Stock	Sale	-$131K	-1.5K	-0.49%	$87.22	304K	Dec 1, 2021	Direct	F1
holding	BMRN	Common Stock						248K	Sep 9, 2021	Shares held by Jean-Jacques Bienaime Family Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 50 shares, with the reporting person's purchase of shares at a price of $78.7700 on September 9, 2021. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

Content

The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 50 shares, with the reporting person's purchase of shares at a price of $78.7700 on September 9, 2021. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.